scispace - formally typeset
P

Patricia D. Hurn

Researcher at University of Texas System

Publications -  118
Citations -  10368

Patricia D. Hurn is an academic researcher from University of Texas System. The author has contributed to research in topics: Stroke & Estrogen. The author has an hindex of 54, co-authored 117 publications receiving 9637 citations. Previous affiliations of Patricia D. Hurn include University of Texas at Austin & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

TL;DR: The updated STAIR preclinical recommendations reinforce the previous suggestions that reproducibly defining dose response and time windows with both histological and functional outcomes in multiple animal species with appropriate physiological monitoring is appropriate.
Journal ArticleDOI

Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System:

TL;DR: Data show for the first time that focal cerebral ischemia results in dynamic and widespread activation of inflammatory cytokines, chemokines, and CCR in the peripheral immune system.
Journal ArticleDOI

Estrogen as a neuroprotectant in stroke.

TL;DR: Gender-specific aspects of clinical and experimental stroke and results of estrogen treatment on outcome in animal models of cerebral ischemia are summarized, and potential vascular and parenchymal mechanisms by which estrogen salvages brain are discussed.
Journal ArticleDOI

Splenic Atrophy in Experimental Stroke Is Accompanied by Increased Regulatory T Cells and Circulating Macrophages

TL;DR: New evidence is provided to support the contention that damage to the brain caused by cerebral ischemia provides a powerful negative signal to the peripheral immune system that ultimately induces a drastic state of immunosuppression caused by cell death as well as an increased presence of CD4+FoxP3+ regulatory T cells.
Journal ArticleDOI

T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.

TL;DR: The data quantify the damaging effect of T and B lymphocytes on early, evolving ischemic brain injury, and further implicate interleukin-1β in brain and interferon-γ and MIP-2 in spleen as inflammatory factors produced by cells other than T andB cells.